Barrett's oesophagus

Barrett's oesophagus is a metaplastic change of the lining of the oesophagus, such that the normal squamous epithelium is replaced by specialised or intestinalised columnar epithelium. The disorder seems to be a complication of chronic gastro-oesophageal reflux disease, although asymptomatic individuals might also be affected, and it is a risk factor for the development of oesophageal adenocarcinoma, a cancer with rapidly increasing incidence in developed societies. We review the presentation, epidemiology, and risk factors for this condition. We discuss the molecular changes necessary for the development of Barrett's oesophagus and its progression to cancer, and new strides in both the endoscopic detection of the lesion and the treatment of dysplastic disease. Also, we assess the effectiveness of efforts to screen patients at risk of Barrett's oesophagus, and whether such efforts avert cancer death. We conclude with a discussion of future directions for research, focusing on treatment of early neoplasia, and modifications of current practices to show our evolving understanding of this condition.

[1]  M. Mayo,et al.  The frequency of Barrett's esophagus in high-risk patients with chronic GERD. , 2005, Gastrointestinal endoscopy.

[2]  M. Eloubeidi,et al.  Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus , 2002 .

[3]  P. Ducrotte,et al.  Screening for Esophagitis and Barrett's Esophagus With Wireless Esophageal Capsule Endoscopy: A Multicenter Prospective Trial in Patients With Reflux Symptoms , 2008, The American Journal of Gastroenterology.

[4]  Peng Wang,et al.  Regulation of Cdx2 expression by promoter methylation, and effects of Cdx2 transfection on morphology and gene expression of human esophageal epithelial cells. , 2006, Carcinogenesis.

[5]  J. Brill,et al.  Cost utility of screening for Barrett's esophagus with esophageal capsule endoscopy versus conventional upper endoscopy. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[6]  M. Blaser,et al.  Caga-positive strains of Helicobacter pylori may protect against Barrett's esophagus , 2000, American Journal of Gastroenterology.

[7]  R. Sandler,et al.  Upper endoscopy as a screening and surveillance tool in esophageal adenocarcinoma: a review of the evidence. , 2002 .

[8]  H. El‐Serag,et al.  Abdominal Obesity and the Risk of Barrett's Esophagus , 2005, The American Journal of Gastroenterology.

[9]  P. Parrilla,et al.  Long-Term Results of a Randomized Prospective Study Comparing Medical and Surgical Treatment of Barrett’s Esophagus , 2003, Annals of surgery.

[10]  J. Peters,et al.  Esophagectomy for High Grade Dysplasia is Safe, Curative, and Results in Good Alimentary Outcome , 2007, Journal of Gastrointestinal Surgery.

[11]  R. Stenling,et al.  The Z-line appearance and prevalence of intestinal metaplasia among patients without symptoms or endoscopical signs indicating gastroesophageal reflux , 2001, Surgical Endoscopy.

[12]  Masoud Panjehpour,et al.  Photodynamic therapy for Barrett's esophagus with dysplasia and/or early stage carcinoma: long-term results. , 2003, Gastrointestinal endoscopy.

[13]  R. Playford.  New British Society of Gastroenterology (BSG) guidelines for the diagnosis and management of Barrett’s oesophagus , 2006, Gut.

[14]  M. Bronner,et al.  Central adiposity and risk of Barrett's esophagus. , 2007, Gastroenterology.

[15]  R. Sampliner,et al.  Correlation of oesophageal acid exposure with Barrett's oesophagus length , 2001, Gut.

[16]  T. Stephenson,et al.  Eradication of dysplastic Barrett's oesophagus using photodynamic therapy: long-term follow-up. , 2003, Endoscopy.

[17]  J. Barkin,et al.  REVIEW: Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma , 2000, Digestive Diseases and Sciences.

[18]  A. Bansal,et al.  The utility of a novel narrow band imaging endoscopy system in patients with Barrett's esophagus. , 2005, Gastrointestinal endoscopy.

[19]  H. Barr,et al.  Improving surveillance for Barrett's oesophagus: AspECT and BOSS trials provide an evidence base , 2006, BMJ : British Medical Journal.

[20]  A. Sonnenberg,et al.  Opposing time trends of peptic ulcer and reflux disease , 1998, Gut.

[21]  R. Goyal,et al.  Prevalence of metaplasia at the gastro-oesophageal junction , 1994, The Lancet.

[22]  J. Hunter,et al.  Office-Based Unsedated Small-Caliber Endoscopy Is Equivalent to Conventional Sedated Endoscopy in Screening and Surveillance for Barrett's Esophagus: A Randomized and Blinded Comparison , 2006, The American Journal of Gastroenterology.

[23]  C. Moskaluk,et al.  Cdx2 as a Marker of Epithelial Intestinal Differentiation in the Esophagus , 2003, The American journal of surgical pathology.

[24]  Patricia L. Blount,et al.  Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets. , 2000 .

[25]  P. Fockens,et al.  Detection and classification of the mucosal and vascular patterns (mucosal morphology) in Barrett's esophagus by using narrow band imaging. , 2006, Gastrointestinal endoscopy.

[26]  R. Sampliner,et al.  Regression of Barrett's esophagus by laser ablation in an anacid environment , 1993, Digestive Diseases and Sciences.

[27]  R. Sandler,et al.  Is there publication bias in the reporting of cancer risk in Barrett's esophagus? , 2000, Gastroenterology.

[28]  D. Faigel,et al.  ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. , 2006, Gastrointestinal endoscopy.

[29]  W H Henricks,et al.  Observer variation in the diagnosis of superficial oesophageal adenocarcinoma , 2002, Gut.

[30]  K. Ragunath,et al.  A randomized, prospective cross-over trial comparing methylene blue-directed biopsy and conventional random biopsy for detecting intestinal metaplasia and dysplasia in Barrett's esophagus. , 2003, Endoscopy.

[31]  J K Greenson,et al.  Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. , 2001, Human pathology.

[32]  R. Sampliner,et al.  Diagnostic inconsistencies in Barrett's esophagus , 1994 .

[33]  R. Sampliner,et al.  Reversal of Barrett's esophagus with acid suppression and multipolar electrocoagulation: preliminary results. , 1996, Gastrointestinal endoscopy.

[34]  A. Ruol,et al.  Oesophageal resection for high‐grade dysplasia in Barrett's oesophagus , 2000, The British journal of surgery.

[35]  Kenneth K Wang,et al.  Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus. , 2002, Gastroenterology.

[36]  J. Peters,et al.  The extent of Barrett's esophagus depends on the status of the lower esophageal sphincter and the degree of esophageal acid exposure. , 1999, The Journal of thoracic and cardiovascular surgery.

[37]  K. Hemming,et al.  Argon beam plasma coagulation as therapy for high-grade dysplasia in Barrett's esophagus. , 2003, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[38]  S. Spechler.  Short and ultrashort Barrett's esophagus--what does it mean? , 1997, Seminars in gastrointestinal disease.

[39]  G. Falk,et al.  Practice patterns for surveillance of Barrett's esophagus in the united states. , 2000, Gastrointestinal endoscopy.

[40]  A. Rastogi,et al.  Detection of Barrett's Esophagus After Endoscopic Healing of Erosive Esophagitis , 2000, The American Journal of Gastroenterology.

[41]  R. Sampliner,et al.  Bile acids in combination with low pH induce oxidative stress and oxidative DNA damage: relevance to the pathogenesis of Barrett’s oesophagus , 2006, Gut.

[42]  Kenneth K Wang,et al.  Updated Guidelines 2008 for the Diagnosis, Surveillance and Therapy of Barrett's Esophagus , 1998, The American Journal of Gastroenterology.

[43]  D. Provenzale,et al.  The perception of cancer risk in patients with prevalent Barrett's esophagus enrolled in an endoscopic surveillance program. , 2005, Gastroenterology.

[44]  Bergein F Overholt,et al.  Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett's esophagus: 1-year follow-up of 100 patients. , 2007, Gastrointestinal endoscopy.

[45]  Prateek Sharma,et al.  Long-term follow-up of Barrett's high-grade dysplasia , 2000, American Journal of Gastroenterology.

[46]  Keith Abrams,et al.  Detection of Intestinal Metaplasia in Barrett's Esophagus: An Observational Comparator Study Suggests the Need for a Minimum of Eight Biopsies , 2007, The American Journal of Gastroenterology.

[47]  Fred S. Drennan,et al.  Blinded comparison of esophageal capsule endoscopy versus conventional endoscopy for a diagnosis of Barrett's esophagus in patients with chronic gastroesophageal reflux. , 2006, Gastrointestinal endoscopy.

[48]  N. Bird,et al.  Prediction of Malignant Potential in Reflux Disease: Are Cytokine Polymorphisms Important? , 2005, The American Journal of Gastroenterology.

[49]  L. Gossner,et al.  Intraepithelial high-grade neoplasia and early adenocarcinoma in short-segment Barrett's esophagus (SSBE): curative treatment using local endoscopic treatment techniques. , 2002, Endoscopy.

[50]  V. Konda,et al.  Is the risk of concomitant invasive esophageal cancer in high-grade dysplasia in Barrett's esophagus overestimated? , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[51]  P. Malfertheiner,et al.  Helicobacter pylori in gastro-oesophageal reflux disease: causal agent, independent or protective factor? , 1997, Gut.

[52]  J. Richter,et al.  Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease. , 1996, Gastroenterology.

[53]  A. Axon,et al.  Randomized crossover study that used methylene blue or random 4-quadrant biopsy for the diagnosis of dysplasia in Barrett's esophagus. , 2006, Gastrointestinal endoscopy.

[54]  R. Poulsom,et al.  Duodenal-content Reflux Into the Esophagus Leads to Expression of Cdx2 and Muc2 in Areas of Squamous Epithelium in Rats , 2007, Journal of Gastrointestinal Surgery.

[55]  R. Donnelly,et al.  The role of smoking and alcohol in metaplasia and cancer risk in Barrett's columnar lined oesophagus. , 1993, Gut.

[56]  D. Provenzale,et al.  Clinical and Demographic Predictors of Barrett's Esophagus Among Patients With Gastroesophageal Reflux Disease: A Multivariable Analysis in Veterans , 2001, Journal of clinical gastroenterology.

[57]  B. Hirschowitz,et al.  Association of obesity with hiatal hernia and esophagitis , 1999, American Journal of Gastroenterology.

[58]  T. Demeester,et al.  Functional foregut abnormalities in Barrett's esophagus. , 1993, The Journal of thoracic and cardiovascular surgery.

[59]  F. Ellis,et al.  Barrett's esophagus: congenital or acquired? An experimental study of esophageal mucosal regeneration in the dog. , 1970, Surgery.

[60]  J. Dent,et al.  The Montreal Definition and Classification of Gastroesophageal Reflux Disease: A Global Evidence-Based Consensus , 2006, The American Journal of Gastroenterology.

[61]  Bergein F Overholt,et al.  Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial. , 2005, Gastrointestinal endoscopy.

[62]  N. Shaheen,et al.  Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett's esophagus? A meta-analysis , 2003, American Journal of Gastroenterology.

[63]  L. Polese,et al.  High-Energy Laser Therapy of Barrett’s Esophagus: Preliminary Results , 2004, World Journal of Surgery.

[64]  G. Block,et al.  Abdominal obesity and body mass index as risk factors for Barrett's esophagus. , 2007, Gastroenterology.

[65]  L. Lovat,et al.  Cyclin A Immunocytology as a Risk Stratification Tool for Barrett's Esophagus Surveillance , 2006, Clinical Cancer Research.

[66]  R. Sampliner,et al.  The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years. , 1997, The American journal of gastroenterology.

[67]  A. Bhattacharyya,et al.  Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up. , 1997, The American journal of gastroenterology.

[68]  R. Odze,et al.  Phenotypic Characteristics of a Distinctive Multilayered Epithelium Suggests That It Is a Precursor in the Development of Barrett's Esophagus , 2001, The American journal of surgical pathology.

[69]  Edward L. Lee,et al.  Bone marrow progenitor cells contribute to esophageal regeneration and metaplasia in a rat model of Barrett's esophagus. , 2008, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[70]  N. Shaheen,et al.  Effect of a New Diagnosis of Barrett's Esophagus on Insurance Status , 2005, The American Journal of Gastroenterology.

[71]  N. Powe,et al.  Methylene blue-directed biopsies improve detection of intestinal metaplasia and dysplasia in Barrett's esophagus. , 2000, Gastrointestinal endoscopy.

[72]  L. Gerson,et al.  Cost-Benefit Analysis of Capsule Endoscopy Compared With Standard Upper Endoscopy for the Detection of Barrett’s Esophagus , 2007 .

[73]  Screening for high-grade dysplasia in gastroesophageal reflux disease: is it cost-effective? , 2000 .

[74]  Amitabh Chak,et al.  Accuracy of endoscopic optical coherence tomography in the detection of dysplasia in Barrett's esophagus: a prospective, double-blinded study. , 2005, Gastrointestinal endoscopy.

[75]  D. Ransohoff,et al.  Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review. , 2002, JAMA.

[76]  K. Kerlikowske,et al.  Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis. , 2003, Gastroenterology.

[77]  R. Goyal,et al.  The histologic spectrum of Barrett's esophagus. , 1976, The New England journal of medicine.

[78]  Kohzoh Imai,et al.  Usefulness of narrow-band imaging endoscopy for diagnosis of Barrett’s esophagus , 2003, Journal of Gastroenterology.

[79]  A. Sonnenberg,et al.  Gastric surgery is not a risk for Barrett's esophagus or esophageal adenocarcinoma. , 2001, Gastroenterology.

[80]  Dawn Provenzale,et al.  Does this patient have Barrett's esophagus? the utility of predicting Barrett's esophagus at the index endoscopy , 1999, American Journal of Gastroenterology.

[81]  A. Zinsmeister,et al.  Prevalence of columnar-lined (Barrett's) esophagus , 1990 .

[82]  Kamran Ayub,et al.  Longitudinal Study of Insulin-like Growth Factor, Insulin-like Growth Factor Binding Protein-3, and their Polymorphisms: Risk of Neoplastic Progression in Barrett's Esophagus , 2007, Cancer Epidemiology Biomarkers & Prevention.

[83]  Dennis M. Riehle,et al.  Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma. , 2001, Gastroenterology.

[84]  A. Sonnenberg,et al.  Hiatal Hernia and Acid Reflux Frequency Predict Presence and Length of Barrett's Esophagus , 2002, Digestive Diseases and Sciences.

[85]  W. Samowitz,et al.  Restoration of squamous mucosa after ablation of Barrett's esophageal epithelium. , 1993, Gastroenterology.

[86]  D. Schaid,et al.  Barrett's esophagus: prevalence in symptomatic relatives. , 2002 .

[87]  D. Lorenz,et al.  Expression of α-methylacyl coenzyme A racemase in the dysplasia carcinoma sequence associated with Barrett's esophagus , 2008, Modern Pathology.

[88]  R. Sandler,et al.  The relationship between gastroesophageal reflux disease and its complications with Barrett's esophagus. , 1997, The American journal of gastroenterology.

[89]  J. Hagen,et al.  Vagal-Sparing Esophagectomy: The Ideal Operation for Intramucosal Adenocarcinoma and Barrett with High-Grade Dysplasia , 2007, Annals of surgery.

[90]  Michael Vieth,et al.  Prevalence of Barrett's esophagus in the general population: an endoscopic study. , 2005, Gastroenterology.

[91]  H. El‐Serag,et al.  Meta-Analysis: Obesity and the Risk for Gastroesophageal Reflux Disease and Its Complications , 2005, Annals of Internal Medicine.

[92]  R. Heitmiller,et al.  Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy. , 1996, Annals of surgery.

[93]  D. Skinner,et al.  Barrett's esophagus. Functional assessment, proposed pathogenesis, and surgical therapy. , 1983, Archives of surgery.

[94]  Kenneth K Wang,et al.  Combined endoscopic mucosal resection and photodynamic therapy for esophageal neoplasia within Barrett's esophagus. , 2001, Gastrointestinal endoscopy.

[95]  P. Devitt,et al.  Prospective randomized controlled trial of argon plasma coagulation ablation vs. endoscopic surveillance of patients with Barrett's esophagus after antireflux surgery. , 2004, Gastrointestinal endoscopy.

[96]  Paul Fockens,et al.  Endoscopic video autofluorescence imaging may improve the detection of early neoplasia in patients with Barrett's esophagus. , 2005, Gastrointestinal endoscopy.

[97]  G. Triadafilopoulos,et al.  Prevalence of Barrett's esophagus in asymptomatic individuals. , 2002, Gastroenterology.

[98]  M. Bissonnette,et al.  Clinical Use of p53 in Barrett's Esophagus , 2006, Cancer Epidemiology Biomarkers & Prevention.

[99]  M. Sivak,et al.  Familial aggregation of Barrett’s oesophagus, oesophageal adenocarcinoma, and oesophagogastric junctional adenocarcinoma in Caucasian adults , 2002, Gut.

[100]  A. Bhattacharyya,et al.  Proton Pump Inhibitors Are Associated with Reduced Incidence of Dysplasia in Barrett's Esophagus , 2004, American Journal of Gastroenterology.

[101]  A. Berstad,et al.  Relationship of overweight to hiatus hernia and reflux oesophagitis. , 1988, Scandinavian journal of gastroenterology.

[102]  M. Fang,et al.  Aberrant arachidonic acid metabolism in esophageal adenocarcinogenesis, and the effects of sulindac, nordihydroguaiaretic acid, and alpha-difluoromethylornithine on tumorigenesis in a rat surgical model. , 2002, Carcinogenesis.

[103]  Kenneth J. Chang,et al.  Endoscopic ablation of Barrett's esophagus: a multicenter study with 2.5-year follow-up. , 2008, Gastrointestinal endoscopy.

[104]  S. Spechler,et al.  Barrett's esophagus. , 1994, Seminars in oncology.

[105]  J. Mecklin,et al.  Gastroesophageal Reflux Disease: Prevalence, Clinical, Endoscopic and Histopathological Findings in 1,128 Consecutive Patients Referred for Endoscopy due to Dyspeptic and Reflux Symptoms , 2000, Digestion.

[106]  B E Bouma,et al.  Diagnosis of specialized intestinal metaplasia by optical coherence tomography. , 2001, Gastroenterology.

[107]  Kenneth J. Chang,et al.  Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia: a U.S. Multicenter Registry. , 2008, Gastrointestinal endoscopy.

[108]  M. Guelrud,et al.  Enhanced magnification endoscopy: a new technique to identify specialized intestinal metaplasia in Barrett's esophagus. , 2000, Gastrointestinal endoscopy.

[109]  A. Shar,et al.  Secondary chemoprevention of Barrett's esophagus with celecoxib: results of a randomized trial. , 2007, Journal of the National Cancer Institute.

[110]  G. Falk,et al.  The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: Report on the cleveland clinic barrett's esophagus registry , 1999, American Journal of Gastroenterology.

[111]  J. Birkmeyer,et al.  Hospital volume and surgical mortality in the United States. , 2002, The New England journal of medicine.

[112]  R. Kiesslich,et al.  In vivo histology of Barrett's esophagus and associated neoplasia by confocal laser endomicroscopy. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[113]  M. Davila,et al.  Features of Gastroesophageal Reflux Disease in Women , 2004, American Journal of Gastroenterology.

[114]  H. Welch,et al.  The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. , 2005, Journal of the National Cancer Institute.

[115]  A. Lindgren,et al.  Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. , 1999, The New England journal of medicine.

[116]  A. Sonnenberg,et al.  Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. , 2001, Gastroenterology.

[117]  J. Goldblum,et al.  Surveillance of patients with Barrett's esophagus for dysplasia and cancer with balloon cytology. , 1997, Gastroenterology.

[118]  O. Cummings,et al.  Screening for Barrett's esophagus in colonoscopy patients with and without heartburn. , 2003, Gastroenterology.

[119]  D. Provenzale,et al.  Health-related quality of life and severity of symptoms in patients with Barrett's esophagus and gastroesophageal reflux disease patients without Barrett's esophagus , 2000, American Journal of Gastroenterology.

[120]  Michael Vieth,et al.  The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria. , 2006, Gastroenterology.

[121]  G. Lapertosa,et al.  Risk factors for Barrett's esophagus: A case‐control study , 2002, International journal of cancer.

[122]  A. Zinsmeister,et al.  Can symptoms predict endoscopic findings in GERD? , 2003, Gastrointestinal endoscopy.

[123]  J. Horwhat,et al.  Cryoablation of Barrett's esophagus: a pilot study. , 2005, Gastrointestinal endoscopy.

[124]  H. Wolfsen,et al.  Barrett's Esophagus Is Common in Older Men and Women Undergoing Screening Colonoscopy Regardless of Reflux Symptoms , 2006, The American Journal of Gastroenterology.

[125]  B. Shadbolt,et al.  Proton‐pump inhibitor therapy and the development of dysplasia in patients with Barrett's oesophagus , 2004, The Medical journal of Australia.

[126]  Dawn Provenzale,et al.  Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk , 1999, American Journal of Gastroenterology.

[127]  Kamran Ayub,et al.  NSAIDs Modulate CDKN2A, TP53, and DNA Content Risk for Progression to Esophageal Adenocarcinoma , 2007, PLoS medicine.

[128]  Janusz Jankowski,et al.  A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop. , 2004, Gastroenterology.

[129]  C. V. Van Itallie,et al.  Claudin-18: a dominant tight junction protein in Barrett's esophagus and likely contributor to its acid resistance. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[130]  M. Aickin,et al.  Risk factors for Barrett's oesophagus: a life history approach to behavioural assessment in the distant past , 1995, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[131]  R. Uibo,et al.  An 18-year follow-up study of chronic gastritis and Helicobacter pylori association of CagA positivity with development of atrophy and activity of gastritis. , 1999, Scandinavian journal of gastroenterology.

[132]  Thomas Rabenstein,et al.  Chromoendoscopy and narrow-band imaging compared with high-resolution magnification endoscopy in Barrett's esophagus. , 2008, Gastroenterology.